T. Rowe Price
London · Seed–Late Stage
Investment thesis
The firm focuses on capital allocation across health sciences and other sectors, emphasizing early-stage investments in medical innovation. The health sciences team invests at very early stages of human trials and sometimes at the conceptual stage, seeking innovations that can shift from concept to reality. The firm prioritizes investments in breakthrough medical technologies, including genetic engineering approaches and protein-level therapeutics that address diseases through novel mechanisms rather than traditional approaches.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 6 of 6 portfolio companiesEnergy ×2New Materials ×2SaaS ×2AI & Machine Learning ×1B2B Marketplaces ×1Biotech ×1Circular Economy ×1Cleantech ×1
HQs:United States×3
Investments · 6 tracked
founders shown can be your intro pathCross River is a bank that combines traditional banking safety and compliance expertise with technology innovation to provide end-to-end financial solutions for partner companies.
Enterprise SoftwareFintechSaaSJersey City, US
Houzz Pro provides software tools for construction and design professionals, including 3D renderings, floor plans, project management, estimates, proposals, invoicing, and takeoffs in a single platform.
Construction TechPropTechSaaS
Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease. The company integrates AI and real-world data to advance clinical development across multiple underserved cardiovascular conditions.
AI & Machine LearningBiotechHealthtechMedical Devices
Lilac Solutions develops direct lithium extraction technology using ceramic ion exchange media, enabling fast, clean, and affordable lithium production from brines for the electric vehicle and battery industries.
CleantechClimate TechEnergyNew MaterialsOakland, US
David Snydacker(President & Chief Technology Officer)
Redwood Materials deploys large-scale energy storage systems for data centers and grid power while recycling batteries to recover critical minerals like lithium, nickel, cobalt, and copper as a domestic source of these materials.
Circular EconomyEnergyNew Materials
JB Straubel(Founder & CEO)in
Teamshares acquires small businesses from retiring owners and facilitates employee stock ownership, creating a permanent home for businesses while providing retiring owners with a reliable exit and employees with ownership opportunities.
B2B Marketplaces
Michael Brown(Founder & CEO)
Frequently asked questions
- What stage does T. Rowe Price invest at?
- T. Rowe Price invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does T. Rowe Price focus on?
- T. Rowe Price focuses on Biotech, Digital Health, Medical Devices, Sector Agnostic.
- Where is T. Rowe Price located?
- T. Rowe Price is headquartered in London, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.